Skip to main content
. 2021 Jun 24;12:3950. doi: 10.1038/s41467-021-24273-8

Fig. 8. Summary of the study.

Fig. 8

Orally administered milk-derived EVs can reduce the primary tumor burden and accelerate metastasis in a context-dependent manner. Milk EVs can induce senescence and EMT in the primary tumor thereby allowing for reduction in primary tumor and acceleration of metastasis. When the primary tumor is resected, milk-derived EVs induce senescence in the metastatic site thereby reducing the proliferation of cells seeded in distant sites.